Ameritas Investment Partners, Inc. Cel Sci Corp Transaction History

Ameritas Investment Partners, Inc.

  • $2.84 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$2.58 - $4.99 $7,391 - $14,296
-2,865 Closed
0 $0
Q2 2020

Aug 05, 2020
BUY
$9.75 - $17.6 $5,265 - $9,504
540 Added 23.23%
2,865 $43,000
Q2 2019

Aug 14, 2019
BUY
$3.77 - $8.67 $8,765 - $20,157
2,325 New
2,325 $19,000

Others Institutions Holding CVM

# of Institutions
71
Shares Held
6.16M
Call Options Held
16.6K
Put Options Held
148K
View Full List

About CEL SCI CORP

CVM Quotes by TradingView
  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $47.3M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email